Role of Leukopenia in Leukocyte Pathology
Changes in the white blood cell system are divided into three main groups.
First, quantitative deviations per unit volume of blood: an increase (leukocytosis) or a decrease (leukopenia).
Second, disturbances in the ratios of different cell types. This includes relative and absolute cytoses ("-philias") and cytopenias, as well as shifts in the leukocyte differential (left shift toward immature forms or right shift dominated by mature and hypersegmented cells).
Third, the biological properties of the leukocytes themselves may change: their biochemical, biophysical, and structural-functional characteristics.
Clinical and Diagnostic Significance
Leukopenia, like leukocytosis, rarely acts as an independent disease. It is a secondary reaction to an underlying pathology. Upon successful treatment of the primary disease, blood parameters (total cell count, ratio of mature forms, absence of degenerative signs) return to normal. Specific treatment of the blood changes themselves is usually not required in such cases.
Nevertheless, quantitative and qualitative deviations have immense diagnostic value. They allow the clinician to:
- Identify the onset of a pathological process.
- Confirm the presence of pathology.
- Monitor the disease progression.
It is critically important to differentiate reactive leukopenias from leukemias—autonomous neoplastic disorders with distinct causes and mechanisms that require targeted therapy.
Classification and Causes
Globally, two main forms of leukopenia are distinguished: primary (congenital or hereditary) and secondary (acquired).
Primary forms manifest predominantly as neutropenias. These include congenital aleukia, familial and cyclic neutropenias, and lazy leukocyte syndrome (Chédiak–Higashi syndrome).
Secondary leukopenias occur under the influence of various factors categorized by their origin:
- Biological: Infectious agents (influenza, measles, viral hepatitis, typhoid fever, rickettsiae), as well as autoantibodies and autoreactive immune cells (e.g., in systemic lupus erythematosus).
- Chemical: Toxic substances (benzene, insecticides) and medications (sulfonamides, barbiturates, antimetabolites, chloramphenicol, isoniazid, alkylating agents, antineoplastic antibiotics).
- Physical: Mechanical trauma and exposure to low doses of ionizing radiation.
Pathophysiological Mechanisms of Leukopenia
A decreased leukocyte count in the blood results from one or more pathogenetic mechanisms:
- Impaired or suppressed leukopoiesis: Reduced production of cells in the hematopoietic tissue.
- Excessive leukocyte destruction: Occurring directly within the vascular bed or hematopoietic organs.
- Leukocyte redistribution: Sequestration of cells in specific vascular beds, leading to a drop in peripheral blood counts.
- Leukocyte loss: Elimination of cells from the body.
- Hemodilution: Fluid overload leading to relative leukopenia, where the absolute body leukocyte mass remains normal, but their concentration drops.
In-Depth: Why Is Leukopoiesis Suppressed?
Suppression of leukocyte production is a primary mechanism. It can be triggered by genetic defects (mutations in genes controlling cell maturation).
Neurohumoral regulation disorders also act as causes: hypothyroid states, hypocorticism, reduced levels of leukotrienes, or decreased sensitivity of leukocyte progenitor cells to them.
Frequently, leukopoiesis suffers due to a lack of essential hematopoietic components: significant deficits of proteins, amino acids, phospholipids, folic acid, and vitamin B12 (cyanocobalamin).
Factors disrupting leukopoiesis are classified by origin (endogenous and exogenous) and nature (infectious and non-infectious). They can be physical agents (low-dose radiation), chemical agents (moderate hypoxia, drug exposure), or biological agents (microbes, immune complexes).
For Comparison: Mechanisms of Leukocytosis
Unlike leukopenia, an increased leukocyte count (leukocytosis) develops through different scenarios. Its main mechanisms include:
- Stimulation of leukopoiesis and active release of cells into the peripheral blood.
- Redistribution of leukocytes.
- Hemoconcentration (blood thickening).
- Neoplastic activation (in leukemias and lymphomas).
Normal leukopoiesis is activated by an increase in stimulators (such as colony-stimulating factors—CSFs) or a decrease in the activity of proliferation inhibitors and cell maturation inducers.